ROCALTROL 0,25 mcg CAPSULAS BLANDAS

( ARTG ) For the management of established post-menopausal osteoporosis by increasing calcium absorption, elevating circulating levels of calcitriol, and reducing vertebral fracture frequency.‍‍‍‍‍‍​​​‍​​​​​​ For the prevention of corticosteriod-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. For the treatment of hypoclacamia in patients with uraemic osteodystrophy, hypoparathyroidism and Vitamin D resistant rickets. INDICATIONS AS AT 4 MARCH 2004: Rocaltrol is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of a traumatic fracture. Rocaltrol is also indicated for the prevention of corticosteriod-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. Rocaltrol is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphatemic rickets.